According to Pieris Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$60.85 Million. In 2022 the company made a revenue of A$38.06 Million a decrease over the revenue in the year 2021 that were of A$43.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.